Author Of 2 Presentations
EVALUATION OF HEALTHCARE CANDIDEMIA AND TREATMENT PROTOCOL IN PEDIATRIC INTENSIVE CARE
Abstract
Background
In recent years, a clear increase has been observed in the incidence of nosocomial fungal infections.
Objectives
The aim of this study is to assess the candida species, treatment approaches and outcomes of candida infections were identified in the pediatric intensive care unit.
Methods
The study was performed from March 2018-March 2019 in a 14-bed tertiary pediatric intensive care in a city hospital. The patients with invasive candidiasis were detected from microbiology laboratary records and medical records were examined retrospectively.
Results
Within one year, a total of 176 patients were treated in the intensive care unit. Of these patients, 28 (15.7%) had candida isolated species . The most common isolated species was C. albicans in 35.7%. Among non-albican species, C. tropicalis was most commonly isolated in 25%, followed by C. parapsilosis observed in 10.7%.
In 5 patients, antifungal treatment was not started because of no systemic findings.
Mortality occurred in 6 of these patients (21%). In 5 patients, the cause of mortality was considered to be candida sepsis. There was no correlation identified between candida species and mortality.
Some of the Candida species were observed to be resistant to fluconazole, flucytosine and caspofungin. Proliferation in patients with mortal progression were resistant species. However, all candida species were susceptible to micafungin.
Conclusion
In this study, duration of intensive care stay and invasive medical proocedures are associated with an increased risk of invasive candidiasis. Additionally, it is confirmed that micafungin is a more appropriate agent that can be chosen for administration of antifungal treatment.
ASSESSMENT OF PIM3 AND PELOD2 SCORES OF CHILDREN WHO CAME FROM THE WAR IN SYRIA
Abstract
Background
Since the civil war in Syria began, millions of Syrians have left the country and been forced to migrate to other countries. Turkey is the country with most migration hosting 3.6 million refugees.
Objectives
The aim of this study was to compare the PIM-3, PELOD-2, PELOD-2 PDR, mortality rates and outcomes of patients who were admitted to the pediatric intensive care unit.
Methods
This was a retrospective study performed between February 2018 and February 2019 at Hatay State Hospital, very close to the Syrian border. The study included 158 patients. Patients were divided into 3 groups as Turkish citizens, those living in Turkey as refugees and those brought from the border.
Results
Of patients, 57 were Turkish citizens, 33 were refugees and 68 were brought from the border. For patients, the mean PIM-3 score was 25.62±27.70, PELOD-2 score was 8.03±4.72 and PELOD2-PDR was 16.07±23.45. The median scores for PIM-3, PELOD-2, and PELOD2-PDR of patients brought from the Syrian border were evaluated to be higher compared to Turkish citizens and refugees. There was no significant difference observed between refugees and Turkish citizens(Table1). Of patients who died, 59.20% comprised patients brought from the border(Table2)
Conclusion
It is considered that the source of the difference between patients brought from the border and living within Turkey may be associated with the continuing war beyond our borders and children experiencing insufficient care conditions.
In conclusion, war doesn't just cause death due to weapons but also due to many different causes and unfortunately, children suffer most because of this situation.